NCT05419739

Brief Summary

There are studies reporting that the survival rate in pediatric patients with abnormal pupillary response is 23% and that pupillary response is effective on mortality and patient outcomes. Studies in the literature examining the effect of pupillary response on mortality and outcome in pediatric patients with traumatic brain injury reported that bilaterally dilated pupils were associated with a higher mortality rate. Considering the literature results, we believe that obtaining the GCS-Pupil score by combining GCS and pupillary reaction in pediatric patients with traumatic brain injury will be effective in predicting patient outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
128

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 15, 2022

Completed
16 days until next milestone

Study Start

First participant enrolled

July 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

June 22, 2022

Status Verified

June 1, 2022

Enrollment Period

1 year

First QC Date

June 10, 2022

Last Update Submit

June 16, 2022

Conditions

Keywords

Brain traumaticGCS-Pupil scorePediatric

Outcome Measures

Primary Outcomes (1)

  • Death rate

    Death

    one year

Secondary Outcomes (1)

  • Adverse functional outcomes

    one year

Study Arms (1)

Group 1

Children under 18 years of age with traumatic brain injury

Other: Glasgow coma scale

Interventions

This scale, which consists of three parameters, includes the best eye response (1-4 points), the best verbal response (1-5 points), and the best motor response (1-6 points). Total score; It is calculated as Eye Response + Verbal Response + Motor Response and takes a value between 3-15 points. The severity of head trauma is evaluated in three categories: mild (GCS 13-15 points), moderate (GCS 9-12 points), and severe (GCS ≤ 8 points).

Also known as: Pediatric Cerebral Performance Category Scoring System
Group 1

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pediatric patients younger than 18 years with traumatic brain injury

You may qualify if:

  • Be under the age of 18,
  • Not having mental and motor developmental retardation,
  • Having had a traumatic brain injury,
  • Alive at admission and followed up for at least 24 hours

You may not qualify if:

  • Eye trauma or severe facial trauma that will affect the assessment,
  • Those under deep sedation,
  • Those who have been administered drugs (Atropine and mydriatic) that will affect the pupillary response.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bursa Provincial Health Directorate University of Health Sciences Bursa Yuksek Ihtisas Training and Research Hospital

Bursa, 16000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Brain Injuries, Traumatic

Interventions

Glasgow Coma Scale

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Trauma Severity IndicesMedical RecordsRecordsData CollectionEpidemiologic MethodsInvestigative TechniquesOrganization and AdministrationHealth Services AdministrationHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and Evaluation

Study Officials

  • AKİF BULUT, MSc

    Uludag University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 10, 2022

First Posted

June 15, 2022

Study Start

July 1, 2022

Primary Completion

July 1, 2023

Study Completion

July 1, 2023

Last Updated

June 22, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared with other researchers.

Locations